Growth Metrics

Oramed Pharmaceuticals (ORMP) Shares Issued (2022 - 2025)

Oramed Pharmaceuticals (ORMP) has disclosed Shares Issued for 2 consecutive years, with -$2000.0 as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Shares Issued rose 99.93% year-over-year to -$2000.0, compared with a TTM value of $2.4 million through Dec 2023, up 3816.13%, and an annual FY2023 reading of $2.4 million, up 1511.09% over the prior year.
  • Shares Issued was -$2000.0 for Q3 2023 at Oramed Pharmaceuticals, down from $2.4 million in the prior quarter.
  • Across five years, Shares Issued topped out at $3.0 million in Q1 2022 and bottomed at -$2.9 million in Q3 2022.